Abstract
The biological properties of preselected liposomal formulations of L-asparaginase (L-ASNase) were studied. Pharmacokinetics studies showed that encapsulation in large liposomes (sDRV; median diameter 1,249 nm) decreased the circulation time of the enzyme, whereas encapsulation in small liposomes (VET: median diameter 158–180 nm) prolonged it by a factor of up to 10. Liposome encapsulation in either VET or sDRV prevents the induction of anti-asparaginase antibodies and mitigates the anaphylatic reaction, as no death occurred in animals presensitized and challenged with liposomal formulation, in contrast to animals treated with the free enzyme. The antitumor activity was also enhanced by liposome encapsulation. The survival of animals bearing P1534 tumors was prolonged by a factor of 2 after treatment with selected liposomal formulations as compared with free enzyme.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received: 25 November 1994/Accepted: 15 December 1995
Rights and permissions
About this article
Cite this article
Gaspar, M., Perez-Soler, R. & Cruz, M. Biological characterization of L-asparaginase liposomal formulations. Cancer Chemother Pharmacol 38, 373–377 (1996). https://doi.org/10.1007/s002800050497
Issue Date:
DOI: https://doi.org/10.1007/s002800050497